Viewing Study NCT06186934



Ignite Creation Date: 2024-05-06 @ 7:55 PM
Last Modification Date: 2024-10-26 @ 3:17 PM
Study NCT ID: NCT06186934
Status: RECRUITING
Last Update Posted: 2024-04-29
First Post: 2023-12-17

Brief Title: Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL in S Korea Patients
Sponsor: Kyowa Kirin Korea Co Ltd
Organization: Kyowa Kirin Co Ltd

Study Overview

Official Title: Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL in S Korea Patients
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The objective of this post-marketing surveillance PMS study is to assess the safety and effectiveness of Nephoxil capsule 500 mg Ferric Citrate 500 mg equivalent to 105 mg Ferric Iron in routine clinical settings
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None